Autosomal Dominant Hypocalcemia
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Hypocalcemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1 [Phase 3]
A Phase 3 trial is evaluating the efficacy and safety of Encaleret versus standard of care in Autosomal Dominant Hypocalcemia (ADH1). The st…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: ADH1 and ADH2 Disease Monitoring Study (DMS)
This clinical trial update notes a disease monitoring study for Autosomal Dominant Hypocalcemia evaluating two investigational agents, ADH-1…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1 [Phase 2]
This update reports the completion and results posting of a Phase 2 trial evaluating encaleret in Autosomal Dominant Hypocalcemia Type 1, fo…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism [Phase 2]
Phase 2 trial comparing recombinant human rhPTH(1-34) to alfacalcidol/hydrochlorothiazide in severe primary hypoparathyroidism with hypercal…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations [Phase 2]
Phase 2 study evaluating NPSP795 effects on calcium-sensing receptor in autosomal dominant hypocalcemia, with PTH and calcium outcomes; stud…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.